January 17, 2023
1 min read
Save
RAPID
Issue: January 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Efficacy and safety of self-administered nasal spray (etripamil, Milestone Pharmaceuticals) in patients who experience paroxysmal ventricular tachycardia in an at-home setting.